CN110317247A - 一种抗口腔致病菌多肽及应用 - Google Patents
一种抗口腔致病菌多肽及应用 Download PDFInfo
- Publication number
- CN110317247A CN110317247A CN201910649981.5A CN201910649981A CN110317247A CN 110317247 A CN110317247 A CN 110317247A CN 201910649981 A CN201910649981 A CN 201910649981A CN 110317247 A CN110317247 A CN 110317247A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- oral cavity
- nucleic acid
- gly
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 62
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 55
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 55
- 244000052769 pathogen Species 0.000 title claims abstract description 23
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 22
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 23
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 23
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 23
- 241000605862 Porphyromonas gingivalis Species 0.000 claims abstract description 21
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 5
- 239000000654 additive Substances 0.000 claims abstract description 4
- 230000000996 additive effect Effects 0.000 claims abstract description 4
- 239000002324 mouth wash Substances 0.000 claims abstract description 4
- 229940051866 mouthwash Drugs 0.000 claims abstract description 4
- 239000000606 toothpaste Substances 0.000 claims abstract description 4
- 229940034610 toothpaste Drugs 0.000 claims abstract description 4
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 206010060976 Bacillus infection Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000007541 cellular toxicity Effects 0.000 abstract 1
- 230000002147 killing effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 6
- 230000002949 hemolytic effect Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 208000010266 Aggressive Periodontitis Diseases 0.000 description 1
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 1
- UAOSDDXCTBIPCA-QXEWZRGKSA-N Arg-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UAOSDDXCTBIPCA-QXEWZRGKSA-N 0.000 description 1
- LLUGJARLJCGLAR-CYDGBPFRSA-N Arg-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LLUGJARLJCGLAR-CYDGBPFRSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- HBJZFCIVFIBNSV-DCAQKATOSA-N Leu-Arg-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O HBJZFCIVFIBNSV-DCAQKATOSA-N 0.000 description 1
- 208000001143 Periodontal Abscess Diseases 0.000 description 1
- 241000605894 Porphyromonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010044016 Tooth abscess Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- RKCAIXNGYQCCAL-UHFFFAOYSA-N porphin Chemical compound N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 RKCAIXNGYQCCAL-UHFFFAOYSA-N 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910649981.5A CN110317247B (zh) | 2019-07-18 | 2019-07-18 | 一种抗口腔致病菌多肽及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910649981.5A CN110317247B (zh) | 2019-07-18 | 2019-07-18 | 一种抗口腔致病菌多肽及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110317247A true CN110317247A (zh) | 2019-10-11 |
CN110317247B CN110317247B (zh) | 2020-10-16 |
Family
ID=68123929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910649981.5A Active CN110317247B (zh) | 2019-07-18 | 2019-07-18 | 一种抗口腔致病菌多肽及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110317247B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3694928B2 (ja) * | 1995-08-07 | 2005-09-14 | 王子製紙株式会社 | 担子菌コリオラス属由来プロモーター活性を有するdna断片 |
US20070006351A1 (en) * | 2004-02-13 | 2007-01-04 | The Scotts Company | Method for regenerating and transforming St. Augustinegrass from embryogenic callus |
CN106432520A (zh) * | 2016-09-22 | 2017-02-22 | 曹蔚 | 一种蛴螬多糖组分及其制备方法和用途 |
-
2019
- 2019-07-18 CN CN201910649981.5A patent/CN110317247B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3694928B2 (ja) * | 1995-08-07 | 2005-09-14 | 王子製紙株式会社 | 担子菌コリオラス属由来プロモーター活性を有するdna断片 |
US20070006351A1 (en) * | 2004-02-13 | 2007-01-04 | The Scotts Company | Method for regenerating and transforming St. Augustinegrass from embryogenic callus |
CN106432520A (zh) * | 2016-09-22 | 2017-02-22 | 曹蔚 | 一种蛴螬多糖组分及其制备方法和用途 |
Non-Patent Citations (3)
Title |
---|
S Y LEE, H J MOON, S KURATA, S NATORI, B L LEE: "Purification and cDNA Cloning of an Antifungal Protein From the Hemolymph of Holotrichia Diomphalia Larvae", 《BIOL PHARM BULL.》 * |
SO YOUNG LEE, HYUN JOO MOON等: "Purification and Molecular Cloning of cDNA for an Inducible Antibacterial Protein of Larvae of a Coleopteran Insect, Holotrichia diomphalia", 《THE JOURNAL OF BIOCHEMISTRY》 * |
海力且木·艾力,刘忠渊: "富含甘氨酸抗菌肽的研究进展", 《生物技术》 * |
Also Published As
Publication number | Publication date |
---|---|
CN110317247B (zh) | 2020-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Arunachalam et al. | Studies on bioprospecting of endophytic bacteria from the medicinal plant of Andrographis paniculata for their antimicrobial activity and antibiotic susceptibility pattern | |
TÜURI et al. | Influence of aqueous extracts of medicinal plants on surface hydrophobicity of Escherichia coli strains of different origin | |
AU2018231408B2 (en) | Phage therapy | |
CN102924574B (zh) | 抗菌肽lz1和该抗菌肽在制备抗菌药物中的用途 | |
Murugan et al. | Antibiofilm activity of Andrographis paniculata against cystic fibrosis clinical isolate Pseudomonas aeruginosa | |
CN104177485B (zh) | 一种扬子鳄抗菌肽Alligatorin6及其应用 | |
CN106543271A (zh) | 抗耐药性感染多肽Cbf‑14‑2及其用途 | |
Yin et al. | A specific antimicrobial protein CAP-1 from Pseudomonas sp. isolated from the jellyfish Cyanea capillata | |
CN105963680A (zh) | 用于抑制/瓦解生物被膜的抑制剂及其应用 | |
CN110305193A (zh) | 一种抗牙龈卟啉单胞菌多肽及应用 | |
CN104163861B (zh) | 一种爬行动物抗菌肽Alligatorin5及其应用 | |
CN110317247A (zh) | 一种抗口腔致病菌多肽及应用 | |
CN104592359A (zh) | 一种林蛙抗菌肽衍生物及其应用 | |
Rahman et al. | Antibacterial efficacy of raw and commercially available honey | |
CN110305194A (zh) | 一种抗菌多肽及应用 | |
CN110272472A (zh) | 一种抗牙龈卟啉单胞菌及具核酸杆菌多肽及应用 | |
Uslu et al. | Antibacterial spectrum of Umckaloabo (Pelargonium sidoides) on upper airway infection agents | |
CN111378023B (zh) | 一种抗变异链球菌多肽及其应用 | |
Shalini et al. | EXPLORATION OF IN-VITRO ANTI-FUNGAL POTENTIAL OF SIDDHA FORMULATION INDIRATHI THRAVAGAM AGAINST CANDIDA ALBICANS USING DISC DIFFUSION ASSAY | |
CN107365363A (zh) | 小分子多肽及其应用 | |
Al-daan et al. | Effect of Piper cubeba Fruits Extract on Bacteriocin Production of E. coli Isolated from Patient with Urinary Tract Infection | |
CN103233019A (zh) | 高效表达重组细菌素的基因工程菌及其构建方法和应用 | |
A-Ameri et al. | Determination the efficiency of camel's urine against multi-drugs resistant Pseudomonas aeruginosa (MDRPA), isolated from effected burns, wounds and ears | |
Khalid | Inhibitory action of aqueous extract of Anethum graveolens on Staphylococcus aureus | |
CN109627314A (zh) | 具有选择性抗大肠杆菌活性的抗菌肽及其活性优化修饰物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Zhongjie Inventor after: Gao Shegan Inventor after: Deng Bo Inventor before: Li Zhongjie Inventor before: Liu Qiwei Inventor before: Deng Bo Inventor before: Gao Shegan |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240305 Address after: D05A, 46th Floor, Building 1, No. 234 Yan'an Third Road, Shinan District, Qingdao City, Shandong Province, 266071 Patentee after: Chiyue Technology (Qingdao) Co.,Ltd. Country or region after: China Address before: No.263, Kaiyuan Avenue, Luolong District, Luoyang City, Henan Province, 471000 Patentee before: HENAN University OF SCIENCE AND TECHNOLOGY Country or region before: China |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 1003, Science and Technology Innovation Building, No. 171 Shandong Road, Shibei District, Qingdao City, Shandong Province, 266071 Patentee after: Chiyue Biotechnology (Qingdao) Co.,Ltd. Country or region after: China Address before: D05A, 46th Floor, Building 1, No. 234 Yan'an Third Road, Shinan District, Qingdao City, Shandong Province, 266071 Patentee before: Chiyue Technology (Qingdao) Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240524 Address after: Room 1003, Science and Technology Innovation Building, No. 171 Shandong Road, Shibei District, Qingdao City, Shandong Province, 266071 Patentee after: Chiyue Biotechnology (Qingdao) Co.,Ltd. Country or region after: China Patentee after: Yanyue Biotechnology (Qingdao) Co.,Ltd. Address before: Room 1003, Science and Technology Innovation Building, No. 171 Shandong Road, Shibei District, Qingdao City, Shandong Province, 266071 Patentee before: Chiyue Biotechnology (Qingdao) Co.,Ltd. Country or region before: China |